Skip to main content
Clinical Trials/NCT03117218
NCT03117218UnknownNot Applicable

Quantitative Analysis of 3T Whole Heart Coronary Magnetic Resonance Angiogram Improves Detection of Functionally Significant Coronary Artery Disease

Seoul National University Bundang Hospital1 site in 1 country89 target enrollmentStarted: July 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
89
Locations
1
Primary Endpoint
Presence of functionally significant coronary stenosis

Study Overview

Brief Summary

This study aims to evaluate whether quantitative analysis of coronary MR angiogram would improve the detection of functionally-significant coronary artery stenosis.

Detailed Description

Coronary MR angiography is performed with a 3.0-T imager with 32-channel coils. Qunatitative analysis of coronary MR angiogram is evaluated on the basis of the signal intensity (SI) profile along the vessel. Quantitative analysis of coronary MR angiogram (QCMRA) is calculated as [1 - (SImin/SIref)] x 100, where SImin is minimal SI and SIref is corresponding reference SI. Diagnostic performance of quantitative analysis of coronary MR angiogram for predicting functional significant coronary stenosis was evaluated by using fractional flow reserve (FFR) as the reference standard.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • 1 or more coronary stenoses in the major coronary artery with a vessel diameter ≥ 2mm on coronary MR angiogram
  • Patient who were planned to undergo invasive coronary angiography and fractional flow reserve

Exclusion Criteria

  • clinically unstable patient
  • a history of coronary revascularization
  • infiltrative cardiomyopathy, hypertropic cardiomyopathy, myocarditis
  • contraindication to use of adenosine
  • complete occlusion of target lesion

Outcomes

Primary Outcomes

Presence of functionally significant coronary stenosis

Time Frame: within 1 month

fractional flow reserve \< 0.8

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yeonyee E Yoon, MD

Associate Professor

Seoul National University Bundang Hospital

Study Sites (1)

Loading locations...

Similar Trials